Amedeo Smart

Free Medical Literature Service


 

Amedeo

Influenza

  Free Subscription

11.07.2022

1 Biochem Biophys Res Commun
2 Biochemistry
1 Biochemistry (Mosc)
1 BMC Pediatr
12 BMJ
2 Epidemiol Infect
1 J Exp Med
2 J Immunol
16 J Infect
1 J Infect Dis
4 JAMA
2 Lancet
3 MMWR Morb Mortal Wkly Rep
9 N Engl J Med
6 Pediatrics
1 PLoS Biol
42 PLoS One
1 Proc Natl Acad Sci U S A
1 Vaccine



    Biochem Biophys Res Commun

  1. LI H, Ren H, Cao L, Guo J, et al
    Comparison of the efficacy and safety of different immunization routes induced by human respiratory syncytial virus F protein with CpG adjuvant in mice.
    Biochem Biophys Res Commun. 2022;618:54-60.
    >> Share


    Biochemistry

  2. CRUZ A, Joseph S
    Interaction of the Influenza A Virus NS1 Protein with the 5'-m7G-mRNA.eIF4E.eIF4G1 Complex.
    Biochemistry. 2022 Jul 7. doi: 10.1021/acs.biochem.2c00019.
    >> Share

  3. FISCHER M, Muller P, Scheidt HA, Luck M, et al
    Drug-Membrane Interactions: Effects of Virus-Specific RNA-Dependent RNA Polymerase Inhibitors Remdesivir and Favipiravir on the Structure of Lipid Bilayers.
    Biochemistry. 2022;61:1392-1403.
    >> Share


    Biochemistry (Mosc)

  4. KUKLINA EM
    T Lymphocytes as Targets for SARS-CoV-2.
    Biochemistry (Mosc). 2022;87:566-576.
    >> Share


    BMC Pediatr

  5. ROSU CA, Martens AM, Sumner J, Farkas EJ, et al
    Heterogeneity in the evaluation of suspected MIS-C: a cross-sectional vignette-based survey.
    BMC Pediatr. 2022;22:392.
    >> Share


    BMJ

  6. OLIVER D
    David Oliver: What can we learn from formal complaints during covid-19?
    BMJ. 2022;378:o1629.
    >> Share

  7. GREWAL R, Kitchen SA, Nguyen L, Buchan SA, et al
    Effectiveness of a fourth dose of covid-19 mRNA vaccine against the omicron variant among long term care residents in Ontario, Canada: test negative design study.
    BMJ. 2022;378:e071502.
    >> Share

  8. WILKINSON E
    Covid-19: GPs are asked to opt into next vaccination phase this autumn.
    BMJ. 2022;378:o1657.
    >> Share

  9. SALISBURY H
    Helen Salisbury: Discouraging self-isolation with covid.
    BMJ. 2022;378:o1637.
    >> Share

  10. WILKINSON E
    Covid-19: Pandemic sickness pay rules for NHS staff to come to an end.
    BMJ. 2022;378:o1648.
    >> Share

  11. WISE J
    Covid-19: Sharp rise in infections seen across the UK.
    BMJ. 2022;378:o1638.
    >> Share

  12. SAUL H, Gursul D, Antonelli M, Steves C, et al
    Frail older people and those in deprived areas remain at risk from covid-19, even after vaccination.
    BMJ. 2022;378:o1313.
    >> Share

  13. JOHNSTON C, Hughes H, Lingard S, Hailey S, et al
    Immunity and infectivity in covid-19.
    BMJ. 2022;378:e061402.
    >> Share

  14. TAYLOR L
    Covid-19: Brazil is recording a fifth of all deaths of under 5s.
    BMJ. 2022;378:o1634.
    >> Share

  15. DYER O
    Covid-19: Canada outperformed comparable nations in pandemic response, study reports.
    BMJ. 2022;377:o1615.
    >> Share

  16. DUVAL D, Palmer JC, Tudge I, Pearce-Smith N, et al
    Long distance airborne transmission of SARS-CoV-2: rapid systematic review.
    BMJ. 2022;377:e068743.
    >> Share

  17. DANCER SJ
    Airborne SARS-CoV-2.
    BMJ. 2022;377:o1408.
    >> Share


    Epidemiol Infect

  18. BENNEDBAEK M, Button MSF, Nielsen LB, Bybjerg-Grauholm J, et al
    Increased transmission of SARS-CoV-2 in Denmark during UEFA European championships.
    Epidemiol Infect. 2022;150:e123.
    >> Share

  19. SARVIKIVI E, Salminen M, Savolainen-Kopra C, Ikonen N, et al
    COVID-19 cases in spectators returning to Finland from UEFA Euro 2020 matches in Saint Petersburg.
    Epidemiol Infect. 2022;150:e121.
    >> Share


    J Exp Med

  20. CHO A, Muecksch F, Wang Z, Ben Tanfous T, et al
    Antibody evolution to SARS-CoV-2 after single-dose Ad26.COV2.S vaccine in humans.
    J Exp Med. 2022;219.
    >> Share


    J Immunol

  21. CUSIMANO GM, Gary EN, Bell MR, Warner BM, et al
    Improved Durability to SARS-CoV-2 Vaccine Immunity following Coimmunization with Molecular Adjuvant Adenosine Deaminase-1.
    J Immunol. 2022 Jun 24. pii: jimmunol.2200056. doi: 10.4049/jimmunol.2200056.
    >> Share

  22. PALANI S, Bansal S, Verma AK, Bauer C, et al
    Type I IFN Signaling Is Essential for Preventing IFN-gamma Hyperproduction and Subsequent Deterioration of Antibacterial Immunity during Postinfluenza Pneumococcal Infection.
    J Immunol. 2022;209:128-135.
    >> Share


    J Infect

  23. WEN F, Zhang X, Guo J, Liang Z, et al
    Emergence of H3N8 avian influenza viruses possessing tri-basic hemagglutinin cleavage sites in China.
    J Infect. 2022 Jul 1. pii: S0163-4453(22)00383.
    >> Share

  24. IJAZ S, Dicks S, Jegatheesan K, Parker E, et al
    Mapping of SARS-CoV-2 IgM and IgG in gingival crevicular fluid: antibody dynamics and linkage to severity of COVID-19 in hospital inpatients.
    J Infect. 2022 Jun 3. pii: S0163-4453(22)00339.
    >> Share

  25. ABDI B, Ndoadoumgue AL, Djebara S, Zafilaza K, et al
    High SARS-CoV-2 seroprevalence in HIV patients originating from sub-Saharan Africa in the Ile-de-France area: Seroprevalence of SARS-CoV-2 in HIV patients.
    J Infect. 2022 Jun 2. pii: S0163-4453(22)00346.
    >> Share

  26. MELLON G, Rouquette A, Fac C, Carton B, et al
    SARS-CoV-2 seroprevalence in the adult detainees of the Paris area in 2021: A multicenter cross-sectional study.
    J Infect. 2022 Jun 2. pii: S0163-4453(22)00345.
    >> Share

  27. ZHANG Y, Li J, Jiang L, Chen Q, et al
    Comparison of SARS-CoV-2 aerosol emission from patients with Omicron BA.1 or BA.2 subvariant infection.
    J Infect. 2022 Jun 1. pii: S0163-4453(22)00342.
    >> Share

  28. NISHIKIMI A, Watanabe K, Watanabe A, Yasuoka M, et al
    Immune responses to COVID-19 vaccine BNT162b2 in workers at a research institute in Japan: 6-month follow-up survey.
    J Infect. 2022 May 20. pii: S0163-4453(22)00307.
    >> Share

  29. LIU L, Fan X, Guan Q, Yu C, et al
    Bioavailable testosterone level is associated with COVID-19 severity in female: A sex-stratified Mendelian randomization study.
    J Infect. 2022 May 13. pii: S0163-4453(22)00287.
    >> Share

  30. VAN GRONINGEN KM, Dao BL, Gounder P
    Declines in invasive pneumococcal disease (IPD) during the COVID-19 pandemic in Los Angeles county.
    J Infect. 2022 May 9. pii: S0163-4453(22)00259.
    >> Share

  31. ZHANG YM, Liu XZ, Lin MM, Zan JC, et al
    Immunosuppression impaired the immunogenicity of inactivated SARS-CoV-2 vaccine in non-dialysis kidney disease patients.
    J Infect. 2022 May 9. pii: S0163-4453(22)00260.
    >> Share

  32. LUCIJANIC M, Cikara T, Bistrovic P, Papic I, et al
    Remdesivir use in COVID-19 patients might predispose bacteremia, matched case-control analysis.
    J Infect. 2022 May 2. pii: S0163-4453(22)00251.
    >> Share

  33. HIROTSU Y, Maejima M, Shibusawa M, Natori Y, et al
    SARS-CoV-2 Omicron sublineage BA.2 replaces BA.1.1: genomic surveillance in Japan from September 2021 to March 2022.
    J Infect. 2022 Apr 28. pii: S0163-4453(22)00247.
    >> Share

  34. GIANNITRAPANI L, Augello G, Mirarchi L, Amodeo S, et al
    Outcome predictors in SARS-CoV-2 disease (COVID-19): the prominent role of IL-6 levels and an IL-6 gene polymorphism in a western Sicilian population.
    J Infect. 2022 Apr 28. pii: S0163-4453(22)00245.
    >> Share

  35. LI A, Zhang L
    Reduced incidence of acute pharyngitis and increased incidence of chornic pharyngitis under COVID-19 control strategy in Beijing.
    J Infect. 2022 Apr 28. pii: S0163-4453(22)00249.
    >> Share

  36. RANA MS, Usman MM, Ikram A, Salman M, et al
    The negative impact of the COVID-19 Pandemic on immunization and the positive impact on Polio eradication in Pakistan and Afghanistan. A dismal scenario.
    J Infect. 2022 Apr 28. pii: S0163-4453(22)00246.
    >> Share

  37. YUAN S, Jiang SC, Zhang ZW, Fu YF, et al
    Surface electrostatic shift on spike protein decreased antibody activities against SARS-CoV-2 Omicron variant.
    J Infect. 2022 Apr 23. pii: S0163-4453(22)00215.
    >> Share

  38. NGUYEN NN, Houhamdi L, Hoang VT, Stoupan D, et al
    High rate of reinfection with the SARS-CoV-2 Omicron variant.
    J Infect. 2022 Apr 23. pii: S0163-4453(22)00216.
    >> Share


    J Infect Dis

  39. WAGNER AL, Sanchez N, Kubale J, Kuan G, et al
    Single dose vaccination among infants and toddlers provides modest protection against influenza illness which wanes after 5 months.
    J Infect Dis. 2022 Jul 7. pii: 6633354. doi: 10.1093.
    >> Share


    JAMA

  40. LARKIN HD
    First Nonprescription COVID-19 Test That Also Detects Flu and RSV.
    JAMA. 2022;328:11.
    >> Share

  41. LARKIN HD
    Expiration Dates Extended on COVID-19 Monoclonal Antibody Therapies.
    JAMA. 2022;328:11.
    >> Share

  42. HAMAD R, Galea S
    The Role of Health Care Systems in Bolstering the Social Safety Net to Address Health Inequities in the Wake of the COVID-19 Pandemic.
    JAMA. 2022 Jun 15. pii: 2793581. doi: 10.1001/jama.2022.10160.
    >> Share

  43. FAUST JS, Du C, Liang C, Mayes KD, et al
    Excess Mortality in Massachusetts During the Delta and Omicron Waves of COVID-19.
    JAMA. 2022 May 20. pii: 2792738. doi: 10.1001/jama.2022.8045.
    >> Share


    Lancet

  44. NASSIRI-ANSARI T, Atuhebwe P, Ayisi AS, Goulding S, et al
    Shifting gender barriers in immunisation in the COVID-19 pandemic response and beyond.
    Lancet. 2022;400:24.
    >> Share

  45. PFAFF F, Hoffmann D, Beer M
    Monkeypox genomic surveillance will challenge lessons learned from SARS-CoV-2.
    Lancet. 2022;400:22-23.
    >> Share


    MMWR Morb Mortal Wkly Rep

  46. CATES J, Baker JM, Almendares O, Kambhampati AK, et al
    Interim Analysis of Acute Hepatitis of Unknown Etiology in Children Aged <10 Years - United States, October 2021-June 2022.
    MMWR Morb Mortal Wkly Rep. 2022;71:852-858.
    >> Share

  47. FLEMING-DUTRA KE, Wallace M, Moulia DL, Twentyman E, et al
    Interim Recommendations of the Advisory Committee on Immunization Practices for Use of Moderna and Pfizer-BioNTech COVID-19 Vaccines in Children Aged 6 Months-5 Years - United States, June 2022.
    MMWR Morb Mortal Wkly Rep. 2022;71:859-868.
    >> Share

  48. DECUIR J, Meng L, Pan Y, Vogt T, et al
    COVID-19 Vaccine Provider Availability and Vaccination Coverage Among Children Aged 5-11 Years - United States, November 1, 2021-April 25, 2022.
    MMWR Morb Mortal Wkly Rep. 2022;71:847-851.
    >> Share


    N Engl J Med

  49. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Designing the Next Covid-19 Vaccine.
    N Engl J Med. 2022;387:e6.
    >> Share

  50. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: How Effective is Covid-19 Vaccination in Children?
    N Engl J Med. 2022;386:e78.
    >> Share

  51. SCHONBORN L, Seck SE, Thiele T, Warkentin TE, et al
    SARS-CoV-2 Infection in Patients with a History of VITT.
    N Engl J Med. 2022 Jun 27. doi: 10.1056/NEJMc2206601.
    >> Share

  52. HACHMANN NP, Miller J, Collier AY, Ventura JD, et al
    Neutralization Escape by SARS-CoV-2 Omicron Subvariants BA.2.12.1, BA.4, and BA.5.
    N Engl J Med. 2022 Jun 22. doi: 10.1056/NEJMc2206576.
    >> Share

  53. QU P, Faraone J, Evans JP, Zou X, et al
    Neutralization of the SARS-CoV-2 Omicron BA.4/5 and BA.2.12.1 Subvariants.
    N Engl J Med. 2022 Jun 15. doi: 10.1056/NEJMc2206725.
    >> Share

  54. HOPKINS S, Hall V, Klenerman P
    Protection against SARS-CoV-2 after Vaccination and Previous Infection. Reply.
    N Engl J Med. 2022;386.
    >> Share

  55. MATUCHANSKY C
    Protection against SARS-CoV-2 after Vaccination and Previous Infection.
    N Engl J Med. 2022;386.
    >> Share

  56. ALTARAWNEH HN, Chemaitelly H, Ayoub HH, Tang P, et al
    Effects of Previous Infection and Vaccination on Symptomatic Omicron Infections.
    N Engl J Med. 2022 Jun 15. doi: 10.1056/NEJMoa2203965.
    >> Share

  57. PERSAD G, Pandya A
    A Comprehensive Covid-19 Response - The Need for Economic Evaluation.
    N Engl J Med. 2022 May 4. doi: 10.1056/NEJMp2202828.
    >> Share


    Pediatrics

  58. CLARK RH, Tolia VN, Ahmad KA
    Palivizumab Use in the NICU: 1999-2020.
    Pediatrics. 2022;150.
    >> Share

  59. CHAIYACHATI BH, Wood JN, Carter C, Lindberg DM, et al
    Emergency Department Child Abuse Evaluations During COVID-19: A Multicenter Study.
    Pediatrics. 2022;150.
    >> Share

  60. FRINTNER MP, Leslie LK, Gottschlich EA, Starmer AJ, et al
    Changes in Work Characteristics and Pediatrician Satisfaction: 2012-2020.
    Pediatrics. 2022;150.
    >> Share

  61. YAN AP, Zipursky AR, Capraro A, Harper M, et al
    Pediatric Emergency Department Sepsis Screening Tool Accuracy During the COVID-19 Pandemic.
    Pediatrics. 2022 May 3. pii: 186991. doi: 10.1542/peds.2022-057492.
    >> Share

  62. SOCHET AA, Morrison JM, Jaffray J, Godiwala N, et al
    Enoxaparin Thromboprophylaxis in Children Hospitalized for COVID-19: A Phase 2 Trial.
    Pediatrics. 2022;150.
    >> Share

  63. FLEMING P, Pereira S, Kapellou O, Claxton A, et al
    Possible In-Utero Transmission of SARS-CoV-2 and Severe Respiratory Disease in a Preterm Infant.
    Pediatrics. 2022 Apr 15. pii: 186766. doi: 10.1542/peds.2021-054557.
    >> Share


    PLoS Biol

  64. TAUBE JC, Miller PB, Drake JM
    An open-access database of infectious disease transmission trees to explore superspreader epidemiology.
    PLoS Biol. 2022;20:e3001685.
    >> Share


    PLoS One

  65. QURESHI A, Syed Sulaiman SA, Kumar N, Qureshi PAAA, et al
    Knowledge, perception, and fear among the global population towards newly evoked variant Omicron (B.1.1.529).
    PLoS One. 2022;17:e0270761.
    >> Share

  66. YIN JH, Song HY, Zeng KX
    Does a smart business environment promote corporate investment? a case study of Hangzhou.
    PLoS One. 2022;17:e0269089.
    >> Share

  67. DIETER C, Brondani LA, Leitao CB, Gerchman F, et al
    Genetic polymorphisms associated with susceptibility to COVID-19 disease and severity: A systematic review and meta-analysis.
    PLoS One. 2022;17:e0270627.
    >> Share

  68. RAUCH S, Arnold L, Stuerner Z, Rauh J, et al
    A true choice of place of birth? Swiss women's access to birth hospitals and birth centers.
    PLoS One. 2022;17:e0270834.
    >> Share

  69. D'ECCLESIIS O, Gavioli C, Martinoli C, Raimondi S, et al
    Vitamin D and SARS-CoV2 infection, severity and mortality: A systematic review and meta-analysis.
    PLoS One. 2022;17:e0268396.
    >> Share

  70. RYU SI, Park YH, Kim J, Huh I, et al
    Impact of COVID-19 on the social relationships and mental health of older adults living alone: A two-year prospective cohort study.
    PLoS One. 2022;17:e0270260.
    >> Share

  71. VAN DEN BULCK S, Crevecoeur J, Aertgeerts B, Delvaux N, et al
    The impact of the Covid-19 pandemic on the incidence of diseases and the provision of primary care: A registry-based study.
    PLoS One. 2022;17:e0271049.
    >> Share

  72. JAMOUSSI A, Ayed S, Merhabene T, Doghri H, et al
    Severe influenza A in a Tunisian ICU sentinel SARI centre: Epidemiological and clinical features.
    PLoS One. 2022;17:e0270814.
    >> Share

  73. RASCHKE RA, Rangan P, Agarwal S, Uppalapu S, et al
    COVID-19 Time of Intubation Mortality Evaluation (C-TIME): A system for predicting mortality of patients with COVID-19 pneumonia at the time they require mechanical ventilation.
    PLoS One. 2022;17:e0270193.
    >> Share

  74. MACHALEK DA, Vette KM, Downes M, Carlin JB, et al
    Serological testing of blood donors to characterise the impact of COVID-19 in Melbourne, Australia, 2020.
    PLoS One. 2022;17:e0265858.
    >> Share

  75. BIBI A, Khan I, Zaman K, Sriyanto S, et al
    Does money buy health? evaluation of stock market performance and economic growth in the wake of the COVID-19 pandemic.
    PLoS One. 2022;17:e0269879.
    >> Share

  76. LINDBERG F, Nelson I, Ranstam J, Riker DK, et al
    Early intervention with a glycerol throat spray containing cold-adapted cod trypsin after self-diagnosis of common cold: A randomised trial.
    PLoS One. 2022;17:e0270699.
    >> Share

  77. MARSHALL S, McNeil N, Seal EL, Nicholson M, et al
    Elite sport hubs during COVID-19: The job demands and resources that exist for athletes.
    PLoS One. 2022;17:e0269817.
    >> Share

  78. SALEH M, Sharma K, Shah J, Karsan F, et al
    A pilot phase Ib/II study of whole-lung low dose radiation therapy (LDRT) for the treatment of severe COVID-19 pneumonia: First experience from Africa.
    PLoS One. 2022;17:e0270594.
    >> Share

  79. NATNAEL T, Adane M, Goraw S
    Hand hygiene practices during the COVID-19 pandemic and associated factors among barbers and beauty salon workers in Ethiopia.
    PLoS One. 2022;17:e0269225.
    >> Share

  80. GELO D, Dikgang J
    Implications of COVID-19 labour market shock for child and household hungers in South Africa: Do social protection programs protect?'
    PLoS One. 2022;17:e0269848.
    >> Share

  81. RITCHIE AI, Kadwani O, Saleh D, Baharlo B, et al
    Clinical and survival differences during separate COVID-19 surges: Investigating the impact of the Sars-CoV-2 alpha variant in critical care patients.
    PLoS One. 2022;17:e0269244.
    >> Share

  82. SOLDEVILA N, Toledo D, Martinez A, Godoy P, et al
    Does knowing the influenza epidemic threshold has been reached influence the performance of influenza case definitions?
    PLoS One. 2022;17:e0270740.
    >> Share

  83. HEO S, Peralta PD, Jin L, Pereira Nunes CR, et al
    Differences in self-perception of productivity and mental health among the STEMM-field scientists during the COVID-19 pandemic by sex and status as a parent: A survey in six languages.
    PLoS One. 2022;17:e0269834.
    >> Share

  84. LASTRUCCI V, Collini F, Forni S, D'Arienzo S, et al
    The indirect impact of COVID-19 pandemic on the utilization of the emergency medical services during the first pandemic wave: A system-wide study of Tuscany Region, Italy.
    PLoS One. 2022;17:e0264806.
    >> Share

  85. SHIRCLIFF K, Liu M, Prestigiacomo C, Fry M, et al
    Mixed methods prospective findings of the initial effects of the U.S. COVID-19 pandemic on individuals in recovery from substance use disorder.
    PLoS One. 2022;17:e0270582.
    >> Share

  86. ORFEUVRE E, Franck N, Plasse J, Haesebaert F, et al
    Mental well-being in young people with psychiatric disorders during the early phase of COVID-19 lockdown.
    PLoS One. 2022;17:e0270644.
    >> Share

  87. JI H, Shin SH, Rogers A, Neese J, et al
    Racial/Ethnic disparities in drug use during the COVID 19 pandemic: Moderating effects of non-profit substance use disorder service expenditures.
    PLoS One. 2022;17:e0270238.
    >> Share

  88. LI X, Zhang A, Al-Zaidy R, Rao A, et al
    Automating document classification with distant supervision to increase the efficiency of systematic reviews: A case study on identifying studies with HIV impacts on female sex workers.
    PLoS One. 2022;17:e0270034.
    >> Share

  89. SANACHAI K, Somboon T, Wilasluck P, Deetanya P, et al
    Identification of repurposing therapeutics toward SARS-CoV-2 main protease by virtual screening.
    PLoS One. 2022;17:e0269563.
    >> Share

  90. MAJER J, Udoh K, Beleke A, Ahmed D, et al
    Operational challenges and considerations for COVID-19 research in humanitarian settings: A qualitative study of a project in Eastern Democratic Republic of the Congo and South Sudan.
    PLoS One. 2022;17:e0267822.
    >> Share

  91. SAVAGE HR, Finch L, Body R, Watkins RL, et al
    A prospective diagnostic evaluation of accuracy of self-taken and healthcare worker-taken swabs for rapid COVID-19 testing.
    PLoS One. 2022;17:e0270715.
    >> Share

  92. ASHOURI M, Phoa FKH
    Interactive tool for clustering and forecasting patterns of Taiwan COVID-19 spread.
    PLoS One. 2022;17:e0265477.
    >> Share

  93. PETRE B, Paridans M, Gillain N, Husson E, et al
    Factors influencing the adoption and participation rate of nursing homes staff in a saliva testing screening programme for COVID-19.
    PLoS One. 2022;17:e0270551.
    >> Share

  94. VICCO A, Caccuri F, Messali S, Vitiello A, et al
    Genomic surveillance of SARS-CoV-2 in patients presenting neurological manifestations.
    PLoS One. 2022;17:e0270024.
    >> Share

  95. VARTANIAN KB, Holtorf M, Cox EJ, Diaz G, et al
    Patient experience and healthcare utilization for a COVID-19 telemedicine home monitoring program offered in English and Spanish.
    PLoS One. 2022;17:e0270754.
    >> Share

  96. JIANG Y, Laranjo JR, Thomas M
    COVID-19 lockdown policy and heterogeneous responses of urban mobility: Evidence from the Philippines.
    PLoS One. 2022;17:e0270555.
    >> Share

  97. AWUNI JA, Ayamga M, Dagunga G
    Covid-19 vaccination intensions among literate Ghanaians: Still the need to dissipate fear and build trust on vaccine efficacy?
    PLoS One. 2022;17:e0270742.
    >> Share

  98. SEID M, Yohanes T, Goshu Y, Jemal K, et al
    The effect of compliance to Hand hygiene during COVID-19 on intestinal parasitic infection and intensity of soil transmitted helminthes, among patients attending general hospital, southern Ethiopia: Observational study.
    PLoS One. 2022;17:e0270378.
    >> Share

  99. COLLINS B, Bandosz P, Guzman-Castillo M, Pearson-Stuttard J, et al
    What will the cardiovascular disease slowdown cost? Modelling the impact of CVD trends on dementia, disability, and economic costs in England and Wales from 2020-2029.
    PLoS One. 2022;17:e0268766.
    >> Share

  100. SPRECKLEY M, de Lange J, Seidell JC, Halberstadt J, et al
    Patient insights into the experience of trying to achieve weight-loss and future expectations upon commencement of a primary care-led weight management intervention: A qualitative, baseline exploration.
    PLoS One. 2022;17:e0270426.
    >> Share

  101. KAMOSHIDA S, Nihonmatsu N, Takagi G, Wakashima K, et al
    The relationship between family variables and family social problems during the COVID-19 pandemic.
    PLoS One. 2022;17:e0270210.
    >> Share

  102. SAAD E, Sadiq S, Jamil R, Rustam F, et al
    Novel extreme regression-voting classifier to predict death risk in vaccinated people using VAERS data.
    PLoS One. 2022;17:e0270327.
    >> Share

  103. AL-NAJJAR MAA, Al-Alwany RR, Al-Rshoud FM, Abu-Farha RK, et al
    Menstrual changes following COVID-19 infection: A cross-sectional study from Jordan and Iraq.
    PLoS One. 2022;17:e0270537.
    >> Share

  104. ZHAO Q, Zhou X, Kuiper R, Curbo S, et al
    Mitochondrial dysfunction is associated with lipid metabolism disorder and upregulation of angiotensin-converting enzyme 2.
    PLoS One. 2022;17:e0270418.
    >> Share

  105. KHATANA SAM, Yang L, Eberly LA, Julien HM, et al
    Predictors of telemedicine use during the COVID-19 pandemic in the United States-an analysis of a national electronic medical record database.
    PLoS One. 2022;17:e0269535.
    >> Share

  106. DROPKIN G
    Variation in COVID-19 booster uptake in England: An ecological study.
    PLoS One. 2022;17:e0270624.
    >> Share


    Proc Natl Acad Sci U S A

  107. YUAN M, Zhu X, He WT, Zhou P, et al
    A broad and potent neutralization epitope in SARS-related coronaviruses.
    Proc Natl Acad Sci U S A. 2022;119:e2205784119.
    >> Share


    Vaccine

  108. HOU Z, Guo J, Lai X, Zhang H, et al
    Influenza vaccination hesitancy and its determinants among elderly in China: A national cross-sectional study.
    Vaccine. 2022 Jul 1. pii: S0264-410X(22)00832.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016